Amgen is shaking up R&D (again), chopping 200 as Genentech targets 130 layoffs
Two biotech giants — Amgen and Genentech — are laying off a combined 330 people at California facilities, both citing “organizational changes” as the primary reason for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.